Skip to main content
SureNano Science logo

SureNano Science — Investor Relations & Filings

Ticker · SURE ISIN · CA86867L1040 CSE Manufacturing
Open in API
Filings indexed 101 across all filing types
Latest filing 2026-04-24 Regulatory Filings
Country CA Canada
Listing CSE SURE

About SureNano Science

https://surenano.com/

SureNano Science is a nanotechnology supply company specializing in advanced cannabis delivery systems. Its principal business is the distribution and sale of the proprietary SureNano™ surfactant, a ready-to-mix, 100% plant-derived, food-grade emulsifying compound. SureNano™ is designed to create highly stable and bioavailable water-dispersible cannabinoid nano-emulsions for infused product makers targeting the edibles, beverages, sprays, and topical markets. The technology ensures ultra-small droplet sizes (40-50 nm), resulting in rapid onset (as fast as 6 minutes) and superior clarity. Key features include Free Flavor technology for taste modulation and Lymphatic Pathway Digestion (LPD) technology, which promotes safer digestion by avoiding liver metabolism. The compound is compliant with FDA and Health Canada food regulations (GRAS to GMP standards). Beyond ingredient supply, the company offers facility setup, supply chain agreements, and knowledge transfer services to partners.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 54% confidence The document is a detailed press release announcing a preclinical FDA toxicology/pharmacology program, potential IP acquisition discussions, multiple investor relations and marketing service agreements, and a stock option grant. It is not an earnings announcement, financial report, AGM material, proxy or management discussion, nor a formal M&A or financing closing. There is no formal submission of results or regulatory form beyond forward-looking statements. Therefore, this fits the fallback category for miscellaneous regulatory/press release filings.
2026-04-24 English
Report of exempt distribution (45-106F1).pdf
Regulatory Filings Classification · 95% confidence The document is a 'Form 45-106F1 Report of Exempt Distribution', which is a standard Canadian regulatory filing used to report the sale of securities to investors under prospectus exemptions. This document details the distribution of units, warrants, and compensation paid to underwriters. Since it is a specific regulatory form required by Canadian securities commissions for capital raising activities, it falls under the 'Regulatory Filings' category as it does not fit into the more specific categories like 'Share Issue' (which usually refers to public offerings or corporate actions) or 'Capital/Financing Update' (which is typically a press release).
2025-12-19 English
Material change report - English.pdf
Audit Report / Information Classification · 95% confidence The document is a press release from G2 Goldfields Inc. announcing the results of a Preliminary Economic Assessment (PEA) for their Oko Gold Project. It contains detailed financial metrics, resource estimates, and project highlights. While it mentions that a formal technical report will be filed later, this document itself serves as the primary announcement of the project's economic viability and strategic outlook, which fits the 'Investor Presentation' or 'Earnings Release' style of corporate disclosure, but most accurately aligns with 'Investor Presentation' (IP) as it details project strategy, economics, and market position for stakeholders. FY 2025
2025-12-19 English
Material change report - English.pdf
Capital/Financing Update Classification · 100% confidence The document is a 'Material Change Report' (Form 51-102F3) filed in Canada, which details a private placement financing transaction. This document is a formal regulatory filing that reports on a specific capital-raising event (issuance of units, shares, and warrants). According to the provided definitions, documents detailing fundraising and financing activities are classified as 'CAP' (Capital/Financing Update).
2025-12-19 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a 'Form 52-109FV2', which is a Venture Issuer Basic Certificate for interim filings. This is a regulatory certification document required by securities legislation to accompany interim financial reports. Since it is a standalone regulatory filing that certifies the accuracy of other reports rather than being the financial report itself, and it does not fit into the specific categories of financial statements or management reports, it is classified as a Regulatory Filing (RNS).
2025-11-19 English
News release - English.pdf
M&A Activity Classification · 100% confidence The document is a press release announcing a non-binding letter of intent (LOI) for a proposed acquisition (M&A activity) of GlucaPharm Inc. by SureNano Science Ltd. It details the structure of the proposed share exchange and mentions a separate private placement. Since the document describes a merger/acquisition proposal, it falls under the M&A Activity category.
2025-11-19 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.